(1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone

C151H171Cl10F5N30O6 — CID 160664353

About (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone

(1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone (PubChem CID 160664353) has the molecular formula C151H171Cl10F5N30O6 and a molecular weight of 2951.75 g/mol. Its IUPAC name is (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone.

Molecular Properties

• Compound Name: (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone
• PubChem CID: 160664353
• Molecular Formula: C151H171Cl10F5N30O6
• Molecular Weight: 2951.75 g/mol
• Exact Mass: 2945.08
• IUPAC Name: (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone
• SMILES: CC(c1ccc(Cl)cc1Cl)n1cnc2ccc(N3CCN(C(=O)C4(C)CCCN4)CC3)cc21.CC(c1ccc(Cl)cc1Cl)n1cnc2ccc(N3CCN(C(=O)[C@H]4CCCCN4)C[C@@H]3C)cc21.CC(c1ccc(Cl)cc1Cl)n1nnc2ccc(C3=CCN(C(=O)C4(N)CCCC4)CC3)cc21.CC(c1ccc(Cl)cc1F)n1cnc2ccc(N3CCN(C(=O)C4(N)CCCC4)[C@H](C)C3)cc21.CC(c1ccc(Cl)cc1F)n1cnc2ccc(N3CCN(C(=O)[C@H]4CCCN4)C[C@@H]3C)cc21.O=C([C@H]1CCCN1)N1CCN(c2ccc3ncn(C(c4ccc(Cl)cc4Cl)C(F)(F)F)c3c2)CC1
• InChI: InChI=1S/C26H31Cl2N5O.C26H31ClFN5O.C25H29Cl2N5O.C25H27Cl2N5O.C25H29ClFN5O.C24H24Cl2F3N5O/c1-17-15-31(26(34)24-5-3-4-10-29-24)11-12-32(17)20-7-9-23-25(14-20)33(16-30-23)18(2)21-8-6-19(27)13-22(21)28;1-17-15-31(11-12-32(17)25(34)26(29)9-3-4-10-26)20-6-8-23-24(14-20)33(16-30-23)18(2)21-7-5-19(27)13-22(21)28;1-17(20-6-4-18(26)14-21(20)27)32-16-28-22-7-5-19(15-23(22)32)30-10-12-31(13-11-30)24(33)25(2)8-3-9-29-25;1-16(20-6-5-19(26)15-21(20)27)32-23-14-18(4-7-22(23)29-30-32)17-8-12-31(13-9-17)24(33)25(28)10-2-3-11-25;1-16-14-30(25(33)23-4-3-9-28-23)10-11-31(16)19-6-8-22-24(13-19)32(15-29-22)17(2)20-7-5-18(26)12-21(20)27;25-15-3-5-17(18(26)12-15)22(24(27,28)29)34-14-31-19-6-4-16(13-21(19)34)32-8-10-33(11-9-32)23(35)20-2-1-7-30-20/h6-9,13-14,16-18,24,29H,3-5,10-12,15H2,1-2H3;5-8,13-14,16-18H,3-4,9-12,15,29H2,1-2H3;4-7,14-17,29H,3,8-13H2,1-2H3;4-8,14-16H,2-3,9-13,28H2,1H3;5-8,12-13,15-17,23,28H,3-4,9-11,14H2,1-2H3;3-6,12-14,20,22,30H,1-2,7-11H2/t17-,18?,24+;17-,18?;;;16-,17?,23+;20-,22?/m01..01/s1
• InChIKey: RMCCEFWXCQLOOD-BXEIZQTPSA-N
• XLogP: 28.98
• TPSA: 358.03 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 30
• Rotatable Bonds: 24
• Heavy Atoms: 202
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2951.75
LogP ≤ 5	28.98
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	30

Frequently Asked Questions

What is the IUPAC name of (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone?

The IUPAC name of (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone (CID 160664353) is (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone.

What is the SMILES notation for (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone?

The canonical SMILES for (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone is CC(c1ccc(Cl)cc1Cl)n1cnc2ccc(N3CCN(C(=O)C4(C)CCCN4)CC3)cc21.CC(c1ccc(Cl)cc1Cl)n1cnc2ccc(N3CCN(C(=O)[C@H]4CCCCN4)C[C@@H]3C)cc21.CC(c1ccc(Cl)cc1Cl)n1nnc2ccc(C3=CCN(C(=O)C4(N)CCCC4)CC3)cc21.CC(c1ccc(Cl)cc1F)n1cnc2ccc(N3CCN(C(=O)C4(N)CCCC4)[C@H](C)C3)cc21.CC(c1ccc(Cl)cc1F)n1cnc2ccc(N3CCN(C(=O)[C@H]4CCCN4)C[C@@H]3C)cc21.O=C([C@H]1CCCN1)N1CCN(c2ccc3ncn(C(c4ccc(Cl)cc4Cl)C(F)(F)F)c3c2)CC1.

What is the InChIKey of (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone?

The InChIKey is RMCCEFWXCQLOOD-BXEIZQTPSA-N. The full InChI is InChI=1S/C26H31Cl2N5O.C26H31ClFN5O.C25H29Cl2N5O.C25H27Cl2N5O.C25H29ClFN5O.C24H24Cl2F3N5O/c1-17-15-31(26(34)24-5-3-4-10-29-24)11-12-32(17)20-7-9-23-25(14-20)33(16-30-23)18(2)21-8-6-19(27)13-22(21)28;1-17-15-31(11-12-32(17)25(34)26(29)9-3-4-10-26)20-6-8-23-24(14-20)33(16-30-23)18(2)21-7-5-19(27)13-22(21)28;1-17(20-6-4-18(26)14-21(20)27)32-16-28-22-7-5-19(15-23(22)32)30-10-12-31(13-11-30)24(33)25(2)8-3-9-29-25;1-16(20-6-5-19(26)15-21(20)27)32-23-14-18(4-7-22(23)29-30-32)17-8-12-31(13-9-17)24(33)25(28)10-2-3-11-25;1-16-14-30(25(33)23-4-3-9-28-23)10-11-31(16)19-6-8-22-24(13-19)32(15-29-22)17(2)20-7-5-18(26)12-21(20)27;25-15-3-5-17(18(26)12-15)22(24(27,28)29)34-14-31-19-6-4-16(13-21(19)34)32-8-10-33(11-9-32)23(35)20-2-1-7-30-20/h6-9,13-14,16-18,24,29H,3-5,10-12,15H2,1-2H3;5-8,13-14,16-18H,3-4,9-12,15,29H2,1-2H3;4-7,14-17,29H,3,8-13H2,1-2H3;4-8,14-16H,2-3,9-13,28H2,1H3;5-8,12-13,15-17,23,28H,3-4,9-11,14H2,1-2H3;3-6,12-14,20,22,30H,1-2,7-11H2/t17-,18?,24+;17-,18?;;;16-,17?,23+;20-,22?/m01..01/s1.

What are the key properties of (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone?

(1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone has a molecular weight of 2951.75 g/mol, XLogP of 28.98, 24 rotatable bonds, 6 hydrogen bond donors, and 30 hydrogen bond acceptors.

Where does this data come from?

All data for (1-aminocyclopentyl)-[(2R)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-2-methylpiperazin-1-yl]methanone;(1-aminocyclopentyl)-[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzotriazol-5-yl]-3,6-dihydro-2H-pyridin-1-yl]methanone;[(3S)-4-[3-[1-(4-chloro-2-fluorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone;[(3S)-4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]-3-methylpiperazin-1-yl]-[(2R)-piperidin-2-yl]methanone;[4-[3-[1-(2,4-dichlorophenyl)ethyl]benzimidazol-5-yl]piperazin-1-yl]-(2-methylpyrrolidin-2-yl)methanone;[4-[3-[1-(2,4-dichlorophenyl)-2,2,2-trifluoroethyl]benzimidazol-5-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone is sourced from PubChem (CID 160664353), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).